Chugai OTC Stock Financials

CHGCF
 Stock
  

USD 27.00  0.28  1.05%   

Financial data analysis helps to double-check if markets are presently mispricing Chugai Pharmaceutical. We were able to break down thirty-four available fundamental indicators for Chugai Pharmaceutical, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Chugai Pharmaceutical financials, including its cash per share, price to earnings to growth, and the relationship between the ebitda and book value per share . Given that Chugai Pharmaceutical has a price to earning of 19.94 X, we suggest you to validate Chugai Pharmaceutical prevailing market performance to make sure the company can sustain itself down the road. Use Chugai Pharmaceutical to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of Chugai Pharmaceutical to be traded at $29.7 in 90 days.
  
Refresh
With this module, you can analyze Chugai financials for your investing period. You should be able to track the changes in Chugai Pharmaceutical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Chugai Most Recent Estimates

Quarterly Earnings Growth YOY
1.78
Diluted Eps
1.72
EPS Estimate Current Year
152.94
EPS Estimate Next Year
145.6
Earnings Share
1.72
Understanding current and past Chugai Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chugai Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Chugai Pharmaceutical's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 43
Chugai Pharmaceutical has less than 43 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Chugai Pharmaceutical otc stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Chugai Pharmaceutical's official financial statements usually reflect Chugai Pharmaceutical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Chugai Pharmaceutical. For example, before you start analyzing numbers published by Chugai accountants, it's critical to develop an understanding of what Chugai Pharmaceutical's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Chugai Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chugai Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Chugai Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chugai Pharmaceutical. Please utilize our Beneish M Score to check the likelihood of Chugai Pharmaceutical's management to manipulate its earnings.

Chugai Pharmaceutical Company Summary

Chugai Pharmaceutical competes with Chevron Corp, Merck, and Pfizer. Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. Chugai Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 7664 people.
InstrumentUSA OTC Stock View All
ExchangeOTC Exchange
Business AddressNihonbashi Mitsui Tower
SectorHealthcare
IndustryDrug Manufacturers—General
BenchmarkDOW
Websitewww.chugai-pharm.co.jp
Phone81 3 3281 6611
CurrencyUSD - US Dollar
You should never invest in Chugai Pharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Chugai OTC Stock, because this is throwing your money away. Analyzing the key information contained in Chugai Pharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Chugai Pharmaceutical Key Financial Ratios

Generally speaking, Chugai Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Chugai Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Chugai Pharmaceutical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Chugai Pharmaceutical reports annually and quarterly.

Chugai Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Chugai Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Chugai Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chugai Pharmaceutical competition to find correlations between indicators driving Chugai Pharmaceutical's intrinsic value. More Info.
Chugai Pharmaceutical is rated third in price to sales category among related companies. It is number one stock in retained earnings category among related companies reporting about  Huge  of Retained Earnings per Price to Sales. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Chugai Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Chugai Pharmaceutical's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chugai Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Chugai Pharmaceutical Systematic Risk

Chugai Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chugai Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Chugai Pharmaceutical correlated with the market. If Beta is less than 0 Chugai Pharmaceutical generally moves in the opposite direction as compared to the market. If Chugai Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chugai Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chugai Pharmaceutical is generally in the same direction as the market. If Beta > 1 Chugai Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
.

About Chugai Pharmaceutical Financials

What exactly are Chugai Pharmaceutical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Chugai Pharmaceutical's income statement, its balance sheet, and the statement of cash flows. Potential Chugai Pharmaceutical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Chugai Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Chugai Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Chugai Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Chugai Pharmaceutical is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Chugai grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Chugai Pharmaceutical July 4, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Chugai Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chugai Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chugai Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Chugai OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chugai Pharmaceutical's daily price indicators and compare them against related drivers.
Information Ratio(0.030966)
Maximum Drawdown12.86
Value At Risk(2.09)
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Chugai OTC Stock analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Is Chugai Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chugai Pharmaceutical. If investors know Chugai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chugai Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.78
Market Capitalization
44.4 B
Quarterly Revenue Growth YOY
1.14
Return On Assets
0.25
Return On Equity
0.35
The market value of Chugai Pharmaceutical is measured differently than its book value, which is the value of Chugai that is recorded on the company's balance sheet. Investors also form their own opinion of Chugai Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Chugai Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chugai Pharmaceutical's market value can be influenced by many factors that don't directly affect Chugai Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.